LabCorp(R) Prices $250 Million in Senior Notes Due 2015

BURLINGTON, N.C., Dec. 9 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that it has priced its $250 million aggregate principal amount of Senior Notes due 2015, pursuant to LabCorp's new shelf registration statement.

LabCorp(R) Announces Proposed Sale of $250 Million in Senior Notes Due 2015

BURLINGTON, N.C., Dec. 8 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that it plans to sell up to $250 million aggregate principal amount of Senior Notes due 2015, pursuant LabCorp's new shelf registration statement.

LabCorp(R) Announces Board Authorization of $500 Million Stock Repurchase Program

Company To Purchase $250 Million Under Overnight Share Repurchase Agreement as Part of Program BURLINGTON, N.C., Dec. 7 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that its Board of Directors has authorized an additional stock

ViroMed Introduces Molecular Tests for Rapid Diagnosis of Respiratory Viruses Including Avian Flu

Real-time PCR Test Quickly Detects and Differentiates the H5N1 Avian Flu Strain from Other More Common Respiratory Virus Strains BURLINGTON, N.C. and MINNEAPOLIS, Dec 01, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- ViroMed Laboratories, Inc., a subsidiary of Laboratory Corporation of

Laboratory Corporation of America(R) Holdings Announces Appointment of David P. King as Chief Operating Officer

BURLINGTON, N.C., Nov 30, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that its Chief Operating Officer, Richard L. Novak has decided to retire on December 31, 2006. LabCorp also announced that Mr.

LabCorp To Present at The Merrill Lynch Health Services Conference

BURLINGTON, N.C., Nov 28, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Bradford T. Smith, Executive Vice President, Corporate Affairs, and William (Brad) Hayes, Executive Vice President and Chief

Roche Diagnostics' AmpliChip(TM) CYP450 Test Now Available From LabCorp(R)

Identifies Genetic Variants in Drug-Metabolizing Enzymes to Help Physicians Manage Medication and Reduce Adverse Drug Reactions BURLINGTON, N.C., Nov. 28 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced the availability of Roche

LabCorp(R) Launches Enhanced HIV Screening Assay

Revolutionary Procedure Helps Identify Newly Infected HIV Patients Up to Six Weeks Sooner than Standard HIV Antibody Screening BURLINGTON, N.C., Nov. 7 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced the introduction of an enhanced HIV

LabCorp(R) Licenses Arcturus' Technology for Characterization of Tumor Cells of Unknown Primary Origin

Partnership Expands Access to New Diagnostic Tool for Cancer-treating Physicians BURLINGTON, N.C., Nov. 1 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH), an industry leader in oncology testing, announced today that it has entered into an agreement

Laboratory Corporation of America(R) Announces 2005 Third Quarter Results

Revenue Increase of 9.1 Percent Drives Operating Cash Flow of $172 Million BURLINGTON, N.C., Oct. 20 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced results for the quarter and nine-months ended September 30, 2005.